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Abstract 19 
The stability of antisense oligonucleotides (ONs) towards nucleases is a key aspect for their possible 20 
implementation as therapeutic agents. Typically, ON stability studies are performed off-line, where the 21 
ONs are incubated with nucleases in solution, followed by their analysis. The problematics of off-line 22 
processing render the detailed comparison of relative ON stability quite challenging. Therefore, the 23 
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development of an online platform based on an immobilized enzyme reactor (IMER) coupled to liquid 24 
chromatography (LC) was developed as an alternative for improved ON stability testing. More in detail, 25 
Deoxyribonuclease I (DNase I) was immobilized on epoxy-silica particles of different pore sizes and 26 
packed into a column for the construction of an IMER. Subsequently, the hyphenation of the IMER with 27 
ion-pair chromatography (IPC) and ion-exchange chromatography (IEC) was evaluated, leading to the 28 
successful development of two online methodologies: IMER-IPC and IMER-IEC. More specifically, natural 29 
and modified DNA and RNA oligonucleotides were used for testing the performance of the 30 
methodologies. Both methodologies proved to be simple, automatable, fast and highly reproducible for 31 
the quantitative and qualitative evaluation of ON degradation. In addition, the extended IMER life time 32 
in combination with a more straightforward control of the reaction kinetics substantiate the applicability 33 
of the IMER-LC platform for ON stability tests and its implementation in routine and research 34 
laboratories. 35 
 36 
1. Introduction 37 
In the last two decades the therapeutic potential of antisense oligonucleotides (ONs) has been firmly 38 
recognized. These single-stranded short nucleic acid chains are designed to hybridize complementary 39 
sequences in DNA, pre-mRNA and mRNA, and in this way, block the expression of a target gene [1-3]. 40 
The main problems related with the development and implementation of therapeutic ONs include their 41 
intracellular delivery, transfection across the membrane and stability against nucleases [2, 3]. In an 42 
attempt to improve upon the latter, many modifications on the phosphodiester backbone, the sugar or 43 
the base moiety have been described for increasing nuclease resistance [2, 3]. For instance, the 44 
phosphorothioate modification is one of the simplest chemical modifications which can be carried out in 45 
the ON [3, 4]. Hereby a non-bridging oxygen of the phosphorus is substituted by a sulfur atom. 46 
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Phosphorothioates have demonstrated high resistance towards nucleases; however, their biggest 47 
drawback is the reduced ON hybridizing ability towards complementary strands [3, 4]. Therefore, many 48 
other chemical modifications and their combinations have been considered in order to seek for an 49 
optimal balance between the hybridization ability of the ONs and their resistance towards nucleases [3-50 
5].  51 
Stability studies of ON have been mainly performed in vitro [4, 6-24]. For this purpose ONs are typically 52 
incubated with a specific nuclease, mixture of nucleases, biological fluid or tissue homogenates, 53 
followed by their analysis in various ways. The initially developed analysis techniques required the usage 54 
of fluorescent or radiolabeled ONs in combination with polyacrylamide gel electrophoresis (PAGE) [6-8, 55 
10, 14, 15, 25] or thin layer chromatography (TLC) [6]. However, those procedures were laborious, often 56 
lacking good sensitivity, and attaining accurate and precise quantitation results remains challenging. 57 
Afterwards, with the increasing use of capillary electrophoresis (CE) [23, 24, 26-28] and liquid 58 
chromatography (LC) [6, 29], labeled ONs were no longer required. The usage of CE has proven to 59 
deliver a base to base resolution for ONs differing by one nucleotide in length. Moreover, the 60 
substitution of polyacrylamide filled capillaries by entangled polymer solutions drastically improved the 61 
reproducibility of the methodology and facilitated its implementation [27, 30]. Nevertheless, the high 62 
ionic strength of the enzymatic incubation media, requires a desalting step of the sample for an 63 
adequate CE analysis [23, 24, 26, 27, 31], complicating in this way the sample manipulation procedure, 64 
affecting the analysis time and reproducibility of the methodology. In contrast, the greater robustness of 65 
LC, in addition to recent advances in the development of higher efficiency columns which are able to 66 
provide a high resolution separation of ONs in the range of 10-mer to 30-mer [29, 30, 32], made this 67 
technique the preferred candidate for ON stability studies in pharmaceutical environments [9, 11, 13, 68 
16, 18, 20-22]. Among the existing LC techniques, ion-pair chromatography (IPC) and ion-exchange 69 
chromatography (IEC) have proven to be suitable for this purpose [20, 24, 29, 30, 33]. Additionally, ON 70 
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separations by IPC and IEC (with a polymeric support), do not occur exclusively based on the length of 71 
the ON, but also depend on the base composition [32]. Thus, discerning between two ON product 72 
fragments which have the same length but a significantly different base composition can be efficiently 73 
achieved using either of these two techniques [30]. Analytical procedures employed thus far for ON 74 
stability share in common the presence of enzymes in solution, for which the reaction is performed by 75 
batch incubation [4, 6, 9-11, 13-16, 18, 19, 25-27] or in online way [34]. Incubation can be performed 76 
using either the enzyme present in solution or immobilized on a solid support. Enzyme immobilization 77 
offers several advantages when compared to enzymatic reactions carried out in solution. In addition to 78 
an easier separation of the enzyme from the reaction products and/or substrate, the immobilization of 79 
enzymes also confers them an increased stability towards mechanical stress, pH, heat, ionic strength 80 
and organic solvents [35-41]. Moreover, once packed into the columns to be used as immobilized 81 
enzyme reactors (IMERs), they can be employed in a continuous operation mode, reducing in this way 82 
the sample manipulation steps, increasing the reproducibility and allowing their reutilization; therefore, 83 
reducing costs and analysis time.  84 
The immobilization of enzymes on solid supports has been widely studied and numerous immobilization 85 
methods and supports which are commonly employed have been reported in literature [35, 36, 38, 40-86 
43]. Several nucleases are commercially available, and a broad variety of combinations can be tested 87 
based on the type of substrate they hydrolyze (DNA or RNA), the type of nucleophilic attack 88 
(exonuclease and/or endonuclease), the nature of the hydrolytic products (mono or oligonucleotides) 89 
and the nature of the bond which is hydrolyzed [44, 45]. Furthermore, factors such as their biological 90 
relevance, kinetic performance and cost, also need to be considered for their application in IMERs.  91 
Deoxyribonuclease I (DNase I), is a 29.1 kDa endonuclease which cleaves the phosphodiester backbone 92 
of double and single stranded DNA, requiring divalent cations as cofactors [46, 47]. The enzyme cleaves 93 
the P-O3’ bond of the DNA backbone, yielding 5’-phosphate oligonucleotides [47-49]. Moreover, DNase I 94 
5 
 
has been used as a powerful footprinting agent and for DNA probing [50, 51]. The immobilization of 95 
DNase I on monolithic supports [52, 53], polymers [54] and magnetic particles [55] has been reported. 96 
Furthermore, the good catalytic performance of the immobilized endonuclease and its low cost, makes 97 
DNase I a good candidate for its implementation in IMERs.  98 
In this study, we describe the construction of an IMER with bovine DNase I, and the evaluation of its 99 
hyphenation with IPC and IEC using natural and modified DNA and RNA ONs. Two online platforms 100 
(IMER-IPC and IMER-IEC) with potential applications in ON stability studies were successfully developed. 101 
To the best of our knowledge, the development of online IMER-LC methodologies for stability testing of 102 
ONs had not been reported yet, and could be of high relevance in the development of improved 103 
antisense ON therapies.  104 
 105 
2. Experimental 106 
2.1 Chemicals 107 
Triethylamine (TEA), acetic acid, adenosine monophosphate (AMP), hydrochloric acid, chloroform, Tris, 108 
NaCl, acetone (HPLC grade), Na2HPO4, EDTA, CaCl2, MgCl2, glycine, (3-Glycidyloxypropyl) 109 
trimethoxysilane (GPTMS) and Deoxyribonuclease I (DNase I) from bovine pancreas (≥400 Kunitz 110 
units/mg of protein) were purchased from Sigma-Aldrich (Steinheim, Germany). Acetonitrile (ACN) HPLC 111 
grade from Fischer Scientific (Loughborough, U.K.) and Milli-Q water (Milipore, Milfold, MA) were used. 112 
All the mobile phases were filtered through 0.22 µm nylon membrane filters (Grace Davison Discovery 113 
Sciences, Lokeren, Belgium). Homo-oligonucleotides of deoxythymidine 15-mer (T15), 20-mer (T20) and 114 
30-mer (T30), deoxyadenosine 30-mer (A30), 12-mer ON (5’-GCA-CAC-CGT-CAG-3’) and a 41-mer ON (5’- 115 
GTT-GGA-TTA-AAC-AAC-CGT-TCC-CGT-CTC-TAT-CAG-CTT-AGT-GT-3’) all based on the phosphodiester 116 
backbone; 15-mer (5’-T*T*T*-T*T*T*-T*T*T*-T*T*T*-T*T*T*-3’) with a phosphorothioate backbone, 117 
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and the 2’ O-methyl RNA 12-mer ON (5’-GCA-CAC-CGU-CAG-3’) were purchased from Eurogentec (Liege, 118 
Belgium). The lyophilized ONs were dissolved in an appropriate volume of Mili-Q water in order to 119 
obtain 100 µM stock solutions. 120 
 121 
2.2 Instrumentation 122 
An Agilent 1100 series HPLC composed of a binary pump and a single wave length detector was 123 
employed for the delivery of the chromatographic mobile phases, while the enzymatic reaction buffer 124 
was delivered to the reactor by a HP 1050 quaternary pump (Agilent Technologies, Waldbronn, 125 
Germany). A CTO-20AC prominence HPLC column oven (Shimadzu, Kyoto, Japan) was used for 126 
controlling the temperature of the IMER. 127 
 128 
2.3 Preparation of epoxy-functionalized silica  129 
Nucleosil 5 µm spherical silica particles (1.2 g) of 300, 1000 and 4000 Angstrom from Macherey-Nagel 130 
(Duren, Germany) were used. The functionalization of the silica particles was carried out by suspending 131 
them in a 10% (v/v) GPTMS solution in acetone at room temperature for 2 h under intense stirring. 132 
Afterwards, the particles were filtered and thoroughly washed with acetone, followed by phosphate 133 
buffer (pH 7.0; 15 mM) containing 0.1 M NaCl and finally with phosphate buffer [56]. The particles were 134 
dried at 37 ℃ and then stored at 4 ℃ until the enzyme immobilization was carried out. 135 
 136 
2.4 Immobilization of DNase I 137 
Three mL of a 5 mg/mL solution of DNase I in phosphate buffer (pH 7.0; 15 mM) was mixed with 1 g of 138 
the functionalized silica particles and stirred at 3000 rpm for 30 min. Subsequently, the mixture was set 139 
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in the fridge (4 ℃) for 12 h. When the immobilization was completed, the enzyme modified silica was 140 
filtered and washed with phosphate buffer. Afterwards, deactivation of the unreacted epoxy groups was 141 
carried out by mixing the particles with a 0.2% (m/v) glycine solution in phosphate buffer and stirring for 142 
2 h at room temperature. Once the deactivation was completed, the particles were filtered and washed 143 
with phosphate buffer containing 0.1 M NaCl, followed by phosphate buffer and then by the reaction 144 
buffer (pH 7.5; 50 mM Tris, 5 mM CaCl2 and 5 mM MgCl2). Finally, the enzyme modified silica particles 145 
were dried at 37 ℃ and stored at 4 ℃ before use. The amount of enzyme bound to the silica particles 146 
was determined from the concentration difference of the DNase I solution before and after the 147 
immobilization using flow injection analysis at 280 nm.  148 
 149 
2.5 Preparation of the IMERs 150 
150 mm x 2.1 mm I.D. stainless steel columns were packed using 5 mL slurry containing 1g of enzyme-151 
silica particles in phosphate buffer (pH 7.0; 15 mM). The slurries where previously homogenized for 10 152 
minutes in an ultrasonic bath and consequently packed in the columns at a constant pressure of 400 bar 153 
for 2h using the phosphate buffer as packing solvent. 154 
 155 
2.6 Kinetic determinations 156 
The biological activity of DNase I was determined by measuring the degradation that a deoxythymidine 157 
30-mer oligonucleotide (T30) experienced under the incubation with this enzyme. For this, Ion-pair 158 
chromatography (IPC) using a XBridge C18 column 50 mm × 4.6 mm I.D. × 3 µm column (Waters, Zellik, 159 
Belgium) was used, and the separation temperature was maintained at 60 ℃. The IP mobile phase was 160 
composed of 100 mM TEA (pH 5.5 adjusted with acetic acid) (A) and ACN (B). The gradient profile 161 
consisted of 0-50 min, 0-16B% and the detection was performed at 260 nm. A calibration curve for the 162 
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T30 ON (0.05-60 µM) was constructed for calculating the amount of T30 in the blank and in the test 163 
samples. The enzyme activity was expressed as the pmol of T30/min degraded under the assay 164 
conditions described in sections 2.6.1 and 2.6.2. 165 
 166 
2.6.1 Activity of free DNase I 167 
A T30 ON (final concentration 1-50 µM) was incubated with DNase I (0.01-0.0005 mg/mL) in 50 mM Tris 168 
buffer pH 7.5, 5 mM CaCl2 and 5 mM MgCl2, at 37 ℃ (final volume of 100 µL) and stirred at 2000 rmp. 169 
The incubation time ranged from 0.5-5 min and the reaction was stopped by adding 10 µL of 0.5 M EDTA 170 
solution. Afterwards, the sample was analyzed by IPC as described in section 2.6. The reaction rate (µM 171 
T30/min) was calculated at the beginning of the reaction in the linear part, and the results were used to 172 
construct the Michaelis–Menten plots [37].  The specific activity was calculated by dividing the enzyme 173 
activity by the amount of dissolved enzyme. Non-linear regression analysis was performed for 174 
calculating the kinetic parameters. 175 
 176 
2.6.2 Activity of immobilized DNase I 177 
The activity of the immobilized DNase I was determined in batch in order to attain similar reaction 178 
conditions to the assay in section 2.6.1. The immobilized DNase I silica particles (10-1 mg) were 179 
incubated with a T30 ON (final concentration 1-50 µM) in 50 mM Tris buffer pH 7.5, 5 mM CaCl2 and 5 180 
mM MgCl2, at 37 ℃ (100 µL) and stirred at 2000 rpm. The vials were incubated for a period ranging from 181 
5-90 min followed by the addition of 10 µL of 0.5 M EDTA solution in order to stop the reaction. 182 
Afterwards, the solutions were filtered through 0.45 µm syringe filters before their instrumental 183 
analyses. The kinetic parameters were determined as described in section 2.6.1. The specific activity was 184 




2.7 Online IMER-LC setup 187 
The employed instrumental setup is depicted in figure 1. This fully automated analytical procedure can 188 
be subdivided in two main events: the reaction and focusing of the analytes (i) and the separation (ii). 189 
Table 1 resumes the chromatographic conditions of the integrated IMER-LC system. 190 
(i) Pump 1, which delivered de reaction buffer, was directly connected to the HP 1100 auto-191 
injector (1-5 µL of injection volumes were used), followed by the IMER which was kept at 192 
37 ℃ during all the experiments. By changing the flow rate passing through the reactor, the 193 
residence time of the sample could be tuned in order to attain the desired degradation rate 194 
for the ONs. The system’s and reactor’s dead volumes were determined by injecting a 1 mM 195 
caffeine solution. The effluent from the bioreactor was mixed with the LC mobile phase 196 
(pump 2) with the aid of a T-piece. In this way, both the initial chromatographic mobile 197 
phase and the reaction buffer, were continuously delivered to the LC column. This 198 
composition and flow rates were kept constant for sufficient time in order to assure that all 199 
the sample plug exited the reactor and focused on the head of the LC column; for instance: 200 
for a reaction buffer flow rate of 50 µL/min (pump 1), the LC separation mobile phase was 201 
kept at 500 µL/min for 40 min, exceeding by this, on average, 4 times the reactor’s dead 202 
volume (Table 1). 203 
(ii) Two separation modes were explored: ion-pair chromatography (IPC) and ion-exchange 204 
chromatography (IEC), and the separation conditions were based on a previously described 205 
methodology [30]. The detection wavelength was fixed to 260 nm and the flow rate was set 206 
to 500 µL/min for both separation modes. For IPC, the same separation conditions were 207 
used as in section 2.6. During the reaction-focusing step, the IPC mobile phase composition 208 
was kept at 100 % of A; after which, the separation process took place, for which the 209 
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reaction buffer flow rate (pump 1) was automatically lowered to 1 µL/min and the IPC 210 
gradient was started (pump 2). The IEC experiments were performed on a polymeric based 211 
analytical column 4 mm × 250 mm DNAPac PA200 protected with a 4 mm × 50 mm DNAPac 212 
PA200 precolumn (Thermo Scientific, Erembodegem-Aalst, Belgium). The column 213 
temperature was set to 25 ℃. The mobile phase consisted of water at pH 11.5 (adjusted 214 
with NaOH) (A) and water with 1.25 M NaCl at pH 11.5 (B). The gradient profile was 0–90 215 
min, 0–90%B. The same conditions as in the IPC methodology were set for pump 1.  216 
It must be pointed out that each pump functioned accordingly to its own elution program and that they 217 
were interconnected via an analog interface for their synchronization; thus, the start of the analysis was 218 
controlled by the ChemStation software from the Agilent 1100 instrument.  219 
 220 
3. Results and discussion  221 
3.1 Immobilization of DNase I  222 
The first goal was to develop a reactor allowing maximal enzymatic activity while maintaining the 223 
residence time to a minimum. Several variables may influence the IMER performance; among them, the 224 
choice of the supporting material and the immobilization chemistry of the enzyme to the support, stand 225 
out as the most critical. An ideal support should be chemically inert to the reaction conditions and 226 
samples. In addition, its physical properties such as porosity, pore size distribution, shape, swelling 227 
capacity and charges, play also an important role in the kinetics of the process [35-38]. Spherical silica 228 
particles were chosen as support for the enzyme as a variety of pore diameters and particle sizes are 229 
available, allowing for example, the optimization of the diffusion process and the pressure drop in the 230 
IMER. In addition, their increased resistance to degradation by contaminating microorganisms and a 231 
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stable morphology towards different solvent conditions, distinct as relevant factors for the development 232 
of an IMER [38, 41, 57, 58].  233 
Many strategies for immobilizing enzymes have been described, and among the most relevant stand the 234 
adsorption and the covalent immobilization [35, 36, 38, 41]. Though covalent immobilization of the 235 
enzyme ensures an increased ruggedness and life time of the reactor, one should take into account that, 236 
due to the drastic reaction conditions used during the covalent immobilization process, enzymatic 237 
activity can be somewhat reduced. 238 
A common, if not the most common crosslinking agent for enzyme immobilization is glutaraldehyde [35, 239 
36, 38]; however, amino-propyl silica is thereby required as starting material, presenting the 240 
disadvantage that ONs strongly adsorb and tail to the unreacted silanol amino functions, rendering this 241 
activation process inadequate for the purpose of the here developed methodology. Therefore in this 242 
work, the immobilization of DNase I was carried out via nucleophilic attack of the amine groups of the 243 
enzyme on the immobilized epoxide groups in silica. Next to the simplicity of this type of silica 244 
activation, this procedure results in quasi inert and stable covalent bonds [38, 41, 56, 59]. In addition, no 245 
adsorption of the ONs onto the support material could be observed when the glycidyloxypropyl bond 246 
chemistry was used as an alternative.  247 
As the accessibility of the substrate to the active sites and its diffusivity in the IMER play an important 248 
role in kinetic reactions, immobilization on 5 µm silica particles with a pore diameter of 300 Å, 1000 Å 249 
and 4000 Å was evaluated. Table 2 shows the amount of enzyme immobilized on the silica supports. It 250 
can be noticed that particles with larger pore diameters attach less enzyme in direct correlation with 251 
their  decreased surface area [60]. This also demonstrates that under the immobilization process 252 
conditions, the larger fraction of the enzyme is expected to immobilize close to the pore mouth and on 253 




3.2 Activity of free and immobilized DNase  256 
Typically the activity of DNase is determined based on the Kunitz hyperchromicity assay [62], in which 257 
the activity of the DNase is manifested as the increase on absorption at 260 nm as a DNA solution is 258 
degraded. The substrate used for activity tests has significative effect over the activity of DNase to 259 
cleave the phosphodiester backbone. DNase is able to cleave both, single and double stranded DNA, 260 
being more active towards this latter one [46]. It has been documented that the sequence also plays an 261 
important role, which has been attributed mainly to the flexibility of the DNA [48]. DNA regions rich in 262 
A/T nucleotides are rather less flexible and therefore a diminished cleavage is expected [63]. In this 263 
study we used a homo-oligonucleotide of deoxythymidine 30-mer (T30) as substrate, as it will provide a 264 
more realistic approach of the DNAse activity towards the goals of the developed methodology, which is 265 
to evaluate the stability single stranded oligonucleotides.  266 
The activity of DNase was calculated as the picomoles of T30 degraded per minute. The determination 267 
was performed in a batch sequence for both the free enzyme and the immobilized enzyme, to maintain 268 
the same incubation conditions, such as the same agitation speed. The activity of the free enzyme was 269 
determined as 6.09x105 pmol T30/min while the retained activity percentage of the immobilize enzyme 270 
was around 0.1% (table 2). The activity decrease upon immobilization is expected, as once immobilized, 271 
the enzyme is somewhat restricted and subjected to conformational adaptations in addition to a limited 272 
access of the substrate to the active sites. Moreover, it needs to be considered that the covalent 273 
immobilization occurs on the multiple regions of the enzyme and that the exposure of the active site 274 
might be impeded, therefore the calculated specific activity values are inherently reduced and might be 275 
not directly correlated with the immobilized amount. Moreover, additional supports and immobilization 276 
techniques might also be explored, what could result in different activities. However, it is important to 277 
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point out at this point that by adjusting the flow rate trough the IMER differences in  the degree of 278 
degradation can be controlled.  279 
By comparing the activity of the immobilized DNase in the 5 µm silica particles of 300 Å, 1000 Å, and 280 
4000 Å it can be noticed that the most active support was the one with an average pore size of 1000 Å 281 
(Table 2). On the other hand, the less active support was the one with the smaller pore sizes, despite of 282 
a larger amount of immobilized enzyme. This suggests that the larger pore sizes allow for a facilitated 283 
interaction of the substrate with active site of the enzyme. This observation is concomitant with   284 
degradation profiles of the T30 ON encountered in the IMERs (Figure 2) tested in the developed 285 
methodology (section 3.3). Also in Figure 2, it can be noticed that the degradation of the 41-mer ON 286 
increases as the pore diameter increments, as can be observed in curves A and B in figure 2 287 
corresponding to the IMERs with 1000 Å and the 300 Å pore diameter particles, respectively. The curve 288 
of the 4000 Å IMER for the 41-mer ON is not presented, as this ON practically degrades in its totality at 289 
the fastest residence time tested in our method (~4 min).  The higher degradation rate observed for 41-290 
mer ON when compared to the T30 ON is related to secondary structure formation resulting in the 291 
presence of a certain degree of duplex structures and also to a mixed nucleotide sequence towards 292 
which DNase I is more active [46]. Additionally, a facilitated diffusion of the larger ON through the IMER 293 
with the larger pore diameters, also explains this significant differences. Most importantly, the 294 
differences in degradation between the ONs are also derived from the DNase I cleavage dependence on 295 
the ON sequence [48, 49, 63]. Although further studies on a broader set of ONs could reveal additional 296 
factors, at this time it is important to note that this setup satisfactorily allows the comparison and 297 




3.3 Online IMER-LC 300 
The ease of operation, automation and reproducibility of LC when combined with the specificity of an 301 
IMER, allows for a highly sensitive methodology to study ON degradation. As in the developed 302 
methodologies, the IMER was assembled in the pre-column configuration, the LC separation conditions 303 
which could in principle cause possible enzymatic denaturation due to organic solvents, salts and pH of 304 
mobile phase, had no effect on the IMER performance. Vice versa, in this setup, the enzymatic reaction 305 
conditions should also not alter the performance of the LC separation. 306 
Typically, in pre-column IMER assemblies, both LC chromatographic pumps run independently by the aid 307 
of a switching valve [36, 39-41, 64]; nevertheless, in the proposed methodologies, the pumping systems 308 
were harmonized and the use of a switching valve was substituted by a T-piece. In this configuration, the 309 
IMER effluent was also continuously percolated through the LC column. This increases the simplicity of 310 
the methodology; however, the IMER reaction conditions may have an impact over the LC separation 311 
performance. Therefore, as first criterion, the IMER reaction conditions must be compatible with the LC 312 
methodology. A second possible drawback of this approach is the band broadening, which might be 313 
caused due to long residence times in the IMER and non-specific interactions of the analytes with the 314 
enzyme and the support material.  315 
As it was required to achieve a high resolution separation of complex ONs mixtures after the reaction, it 316 
was critical that the analytes properly focused at the head of the separation column once they emerged 317 
from the IMER. As this methodology avoids a switching valve which might allow coupling a trapping 318 
column, the LC mobile phase must allow for a proper focusing of the analytes as such.  319 
Ion-pair chromatography (IPC) and Ion-exchange chromatography (EIC) were investigated as those LC 320 
methodologies have demonstrated to be suitable for a high resolution separation of therapeutic ONs 321 
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[29, 30]. In addition, the IMER reaction buffer (Tris 50 mM, pH 7.5, CaCl2 5 mM, MgCl2
 5 mM) was 322 
compatible with those LC mobile and stationary phases.  323 
 324 
3.3.1 Online IMER-IPC 325 
IPC has been widely used to purify ONs; therefore, the efficient focusing effect of the hydrophobic ion-326 
pair formed between the negatively charged ON and triethylamine (TEA) to an octadecyl silane (C18) 327 
stationary phase has been documented [29, 33].  328 
Firstly, the focusing of the ONs in IPC under different mixtures ratios of IPC initial mobile phase (TEA 100 329 
mM, pH 5.5) with the IMER reaction buffer was explored in the absence of the IMER and by injecting a 330 
poly-T ON mixture under a defined flow rate in pump 1 and pump 2. The conditions were maintained for 331 
a defined time, which was established as the time necessary to elute at least 2 to 5 IMER volumes by the 332 
flow rate of P1. The tested flow rate ratios (pump 2/pump 1) varied between 2.5 and 20, corresponding 333 
to a flow rate ratio pump 2/pump 1 of 500/200 µL/min to 500/25 µL/min, respectively. Those flow rates 334 
were mainly dependent on the operational pressure limits in pumps 1 and 2 and the fact that an 335 
adequate elution flow rate for the LC separation must be set. Therefore, the flow rate in pump 2 was 336 
maintained at 500 µL/min during all the experiments. It must be pointed out that the pressure drop 337 
observed in pump 1 with the IMER at a flow rate of 200 µL/min was around 250 bar. In addition, the 338 
pressure experienced by pump 1 was also influenced by the pressure drop in pump 2. As consequence, 339 
pump 1 was operating near its pressure limit (400 bar) when a flow rate of 500 and 200 µL/min were 340 
used in pump 2 and pump 1, respectively. Under the applied conditions before the start of the gradient 341 
in pump 2, no breakthrough and satisfactory peak focusing of the ONs was observed. The gradient 342 
elution was achieved by programming the pumps in such way that once the focusing was performed, 343 
pump 1 automatically reduced the flow rate to 1 µL/min and pump 2 started the gradient program. In 344 
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this way the influence of the reaction media over the separation profile was diminished. This was 345 
possible as both pumps were programmed independently and as they were interconnected by an analog 346 
interface for their synchronization with the LC injector.  347 
Finally, the peak shapes and efficiencies were compared, and no significant loss in resolution was 348 
observed down to a pump 2/pump 1 flow ratio of 5. If higher flow rates are required in pump 1 to 349 
establish shorter residence times in the IMER, the flow rate in pump 2 must be concomitantly increased 350 
in order to maintain a pump 2/pump 1 flow rate proportion of at least of 5 for a subsequent highly 351 
efficient separation. Note that the system pressure limit becomes the boundary condition in this set up, 352 
which can in principle be easily solved by reducing the pressure drop in pump 1 through the use of 353 
larger particles, shorter columns or broader columns in the IMER configuration. 354 
Figure 3-A and 3-B show the chromatograms of the 41-mer ON using a blank reactor (epoxy-silica 355 
deactivated with glycine) and the IMER, respectively. A flow rate of 50 µL/min was used in pump 1, and 356 
was maintained for 40 min in order to elute at least 4 IMER volumes. The effect of the IMER on the ON 357 
can be clearly observed, and the main degraded fragments can be resolved using this chromatographic 358 
technique.  359 
Subsequently, the usage of an internal standard was explored as one potential application of this 360 
methodology is to perform quantitative degradation studies. Caffeine (1 mM) was used as internal 361 
standard (IS) as it demonstrated not to interact with the IMER, and also presented sufficient focusing in 362 
the methodology. However, the variation of the peak shape of the IS was noticeable at different 363 
residence times, and was not suitable for a focusing period which exceeded 6 times the IMER volume. 364 
By exceeding 4 times the IMER volume, it could be ensured that all the sample bands eluted from the 365 
IMER. On the other hand, this drastically extended the analysis time, particularly when long residence 366 
times were used. However, by comparing the area of the internal standard at different focusing times 367 
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and IMER residence periods, no significant differences on the peak areas were observed up to 1.5 IMER 368 
volumes. To deliver degradation profiles that do not only focus on  the degradation of the main 369 
compound, the residence time was tuned to allow the proper detection of the degraded peaks which 370 
might not be detected if the activity of the reactor is too high as they also subjected to degradation. The 371 
300 Å IMER was therefore employed for attaining the uncomplete degradations profiles presented in 372 
this paper, as if more active reactors are used the flow rate trough the IMER must be increased, what 373 
increases the system pressure and mobile phase consumptions.   374 
 375 
3.3.2 Online IMER-IEC 376 
It is known that IEC generates higher peak capacities and similar peak shapes for A, T, C , G and U homo-377 
oligonucleotides in comparison to IPC, were ONs rich in C and G are poorly separated [29, 30]. 378 
Therefore, the hyphenation of the IMER with IEC was also investigated. The same experiments as in the 379 
IPC approach were performed in order to explore the focusing of the ONs in this IEC variant. The ONs 380 
focused without any problem, and flow rates ratios pump 2/pump 1 up to 2.5 were successfully tested. 381 
Higher flow rates (>200 µL/min) could be used in pump 1 without any consequences on the LC 382 
performance; nevertheless, they were not fully explored as the pressure drop in pump 1 almost reached 383 
its operational limits with the IMERs. Is important to point out that the pressure experienced by pump 2 384 
with the 25 cm IEC column at 500 µL/min did not exceed 100 bar; however, the operational pressure 385 
limit of this column is 250 bar. 386 
Figure 4-A and 4-B, depict the chromatograms of the 41-mer ON using a blank reactor and the IMER 387 
respectively. The same instrumental conditions were used as for the chromatograms in figure 3 with the 388 
exception for the injection volume, which was increased to allow for an improved detection. Adenosine 389 
monophosphate (AMP) was employed as IS (1 mM), and it demonstrated to focus in an excellent way, in 390 
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the same extent as the ONs. The higher peak capacity in the IEC methodology can be assessed after 391 
comparing the chromatograms of figures 3 and 4. An important aspect to emphasize in the IEC 392 
methodology is that the separation must be performed under denaturing conditions (pH>10.5) [30, 32], 393 
as the reaction fragments can experience hydrogen bond interactions between them, which would lead 394 
to unreproducible degradation profiles if the separation was to be performed at lower pH values. 395 
 396 
3.4 Stability evaluation of antisense ONs 397 
A number of natural and modified ONs were subsequently tested with the developed IMER-LC 398 
methodologies for the evaluation of the performance of the method in stability assessments. The 399 
degradation profiles were recorded for both methodologies (IMER-IPC and IMER-IEC) and comparisons 400 
with the respective blanks were carried out.  401 
The improved, but not complete resistance towards DNase I of the phosphorothioate modification is 402 
visualized in figure 5, where plots A and B correspond to a T15 phosphodiester ON, while plots C and D 403 
to a the phosphorothioate ON. It can be observed that after ~50 min of residence time in the IMER, the 404 
T15 ON is practically completely degraded (plot B compared to its blank plot A), while the T15- 405 
phosphorothioate ON only slightly degraded (plot D compared to its blank plot C). In the plots E to H the 406 
specificity of the IMER towards DNA ONs is demonstrated, as the RNA ON passes intact through the 407 
IMER (plots G and H). 408 
Changes in the degradation profiles when injecting a mixture of ONs demonstrate the applicability of the 409 
methodology for footprinting analysis and/or cleavage protection carried out by a hybridization process 410 
for instance. Hybridization between the A30 and T30 ONs was tested for that purpose. The differences 411 
in the degradation profiles are visualized in figure 6, where plot A corresponds to the analysis of a (T30, 412 
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A30) ON mixture in the blank IMER, while plots B, C and D depict the degradation profiles of a single 413 
stranded A30 ON, a single stranded T30 ON and of the (A30, T30) ON duplex, respectively.   414 
Moreover, similar ON degradation profiles consisting mainly of nucleotide deletions form the main 415 
compound as observed in figure 6 have been observed in vivo [31] and in vitro metabolism studies of 416 
ONs [23, 24, 31]  as well as for small interfering RNA (siRNA) [20-22]. This proves the utility of the 417 
developed methodologies as no sample preparation methodologies are required previous to the 418 
instrumental analysis. Furthermore, under this approach the usage of only one enzyme can be extended 419 
to multiple enzymes to deliver more representative information on the metabolism of this molecules. 420 
One of the advantages of the usage of IMERs is their stability and extended life time. Indeed, the IMERs 421 
demonstrated to be highly active even up to 3 months after their construction, a period during which 422 
they were subjected to analysis and storage conditions (4 ℃). Figure 7 shows the degradation profile of 423 
a (T30, A30) ON mixture tested on the 300 Å IMER after 3 months from its manufacturing. Furthermore, 424 
the high reproducibility of the methodology can also be visualized in figure 7, where the degradation 425 
profiles obtained during three consecutive days are presented. Additionally, the relative standard 426 
deviation (RSD) on the area of selected product peaks is also displayed. The %RSD did not exceed 15%, 427 
and such high values, have been only been observed for the smallest product peaks, while for larger 428 
product fragments the RSDs were around 5%. The average %RSD in all cases was below 10%, which is 429 
exceptionally good as it was measured on the generated degradation fragments, demonstrating the 430 
potential of the methodology for performing online quantitative degradation studies. Note that the 431 
%RDS on the retention times were below 0.1% for all the cases.  432 
The limits of detection (LOD) of the IMER-LC methodologies are determined by the signal to noise ratio 433 
(S/N=3) [64]. The calculated LOD values for the 12-mer and the 41-mer ONs are shown in table 3. Two 434 
LOD values were determined, one corresponding to the instrumental LOD, determined by injection of 435 
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the ONs trough a blank IMER, and the IMER-LC LOD, which was determined using the IMER. This last 436 
LOD, was calculated based on the product fragments rather than by the main peak, and was defined as 437 
the concentration where at least 80% of the fragments in a degradation profile were detected with a 438 
S/N=3. This LOD is dependent on the residence time, as the number and intensity of the generated 439 
fragments are strongly influenced by it. Nevertheless, this LOD provides a useful insight for setting on 440 
analyses with this setup. In general, somewhat higher LODs were observed for the IMER-IEC 441 
methodology when compared to the IMER-IPC, and were attributed to the higher signal noise ratio 442 
generated by the IEC mobile phase containing 1.25 M NaCl. 443 
 444 
4. Conclusion 445 
An online IMER-LC platform for the stability evaluation of antisense DNA ONs was developed. IPC and 446 
IEC were successfully coupled with a DNase I IMER. More in detail, the IMER-IEC method presented a 447 
higher resolving power for the ON degradation products when compared to the IMER-IPC method. On 448 
the other hand, the latter allows for easier hyphenation with mass spectrometry [29, 65]. In addition to 449 
the extended life time of the IMER, both methodologies showed a high reproducibility in area and 450 
retention time. This platform demonstrates potential for application in laboratories where stability tests 451 
of ONs are often performed. Moreover, the construction of IMERs with other endonucleases and 452 
exonucleases, specific or not to the sugar and their coupling to LC should also be explored, as this would 453 
cover stability assessments of a much wider range of ON modifications. Furthermore, the construction 454 
of an IMER containing multiple nucleases, based either on the simultaneous immobilization of various 455 
nucleases to a support or by the interconnection of IMER subunits is promising, as many nucleases share 456 
the same activation conditions by divalent cations such as Ca2+ and Mg2+, allowing for an easy 457 
hyphenation with LC. Implementation of the here described methodology for nuclease resistance 458 
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assessment will allow generation of uniform and reliable data, finally enabling reliable comparison of 459 
different approaches towards enhancement of nucleic acid stability, which is of prime importance in the 460 
fast developing field of ON based drug development. 461 
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Figure 2. Oligonucleotide degradation in the the 300 Å, 1000 Å, 4000 Å IMERs. A T30 ON and the 41-mer ON are compared. The 634 
degradation percentage is plotted against de residence time in the IMER. The confidence interval (α=0.05, n-1 d.f.) of the mean 635 






Figure 3. IMER-IPC chromatograms of a 41-mer ON. A) blank IMER; B) DNase I IMER. ~10 min of residence time in the 300 Å 640 
IMER (Flow rate of pump 1 = 50 µL/min). The sample was allowed to focus for 40 min before the LC gradient start. IS: internal 641 




Figure 4. IMER-IEC chromatograms of a 41-mer ON. A) blank IMER; B) DNase I IMER. ~10 min of residence time in the 300 Å 646 
IMER (Flow rate of pump 1 = 50 µL/min). The sample was allowed to focus for 40 min before the LC gradient start. IS: internal 647 










Figure 5. IMER-IPC chromatograms. The analyzed ON sample is indicated for each chromatogram. A), C), E) and G) correspond 656 
to a blank IMER, while B), D), F) and H) to the DNase I IMER. ~50 min of residence time in the 300 Å IMER (Flow rate of pump 1 657 
= 10 µL/min). The sample was allowed to focus for 80 min before the LC gradient start. IS: internal standard, caffeine 1 mM. 658 








Figure 6. IMER-IEC chromatograms. The analyzed ON sample is indicated for each chromatogram. A) corresponds to a blank 665 
IMER, while B), C) and D) to the DNase I IMER. ~50 min of residence time in the 300 Å IMER (Flow rate of pump 1 = 10 µL/min). 666 
The sample was allowed to focus for 80 min before the LC gradient start. Injection: 10 µL of a 50 µM ON solution. Each ON is 667 
















Figure 7. Three IMER-IEC chromatograms of a (T30, A30) ON mixture analyzed during 3 consecutive days in a 3 months old 300 682 
Å IMER. The %RSD on the area is indicated for few peaks. ~50 min of residence time in the IMER (Flow rate of pump 1 = 10 683 
µL/min). The sample was allowed to focus for 80 min before the LC gradient start. Injection: 5 µL of a 50 µM ON solution. No 684 
internal standard was employed. 685 
 686 
 687 
Table 1. Chromatographic conditions of the IMER-LC setup. 688 
Flow rate (µL/min) 






0.00-40.00 (i) Elution of the analytes 
trough the IMER and focusing 




a40.01-90.00 (ii) Separation of the analytes 
by the analytical column b40.01-130.00 
a Ion-pair chromatography (A: 100 mM TEA, pH 5.5; B: ACN) 689 
b Ion-exchange chromatography (A: H2O, pH 11.5; B: 1.25 NaCl, pH 11.5) 690 
 691 
 692 






DNase I (mg/g)a 
Activity/support 
(pmol T30/min·g) 
300 Å 0.8 8.2 ± 0.3 123.8 ± 42.5 
1000 Å 0.8 6.1 ± 0.2 643.3 ± 156.0 
4000 Å 0.7 4.9 ± 0.1 361.8 ± 23 
5 µm silica particles where employed. 694 
The free DNase I used for immobilization has a specific activity of 6.09x105 pmol T30/min·g 695 













IPC IEC IMER-IPC IMER-IEC 
12-mer ON 0.01 0.11 0.18 1.1 
41-mer ON 0.03 0.12 0.63 1.3 
The values are given in µg/µL concentrations and considering an injection volume of 1 µL. 702 
Only DNA based ON were tested. 703 
a Determined with a blank IMER, S/N=3. 704 
b Determined under a flow rate of 50 µL/min trough the 300 Å IMER and considering a detection of 80% of the product fragments with a S/N=3. 705 
 706 
 707 
 708 
 709 
 710 
 711 
